Related Experiment Videos
US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved
Danelle Hidano1, Sanket S Dhruva2, Rita F Redberg2
1University of Washington, Seattle.
JAMA Internal Medicine
|March 14, 2022
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Echocardiographic characteristics of new-onset methamphetamine-associated heart failure: a retrospective cohort study.
Echo research and practice·2026
Coverage Limitations for Use of Urine Drug Testing in a State Medicaid Program.
JAMA network open·2026
From Registry to Reality: Opportunities to Enhance Post-market Surveillance of High-Risk Medical Devices Comment on "Quality and Utility of European Cardiovascular and Orthopaedic Registries for the Regulatory Evaluation of Medical Device Safety and Performance Across the Implant Lifecycle: A Systematic Review".
International journal of health policy and management·2026
Evaluation of Payer Policies to Reduce Low-Value Medical Device-Based Procedure Use.
JAMA health forum·2025
Comparative Effectiveness of Phenobarbital vs Diazepam for Alcohol Withdrawal Syndrome.
JAMA internal medicine·2026
Fasting Duration and Differences Across Routine Laboratory Tests.
JAMA internal medicine·2026
Whole-Food Protein Sources Differentially Modulate Postprandial Plasma Dileucine Profiles in the Post-Exercise State.
Molecular nutrition & food research·2026
High Fat Diet Alters Gastrointestinal Function and Results in Reduced Enteric Neuron Density.
Neurogastroenterology and motility·2026